Typ-1-Diabetes Merkmale unter dem Mikroskop

• Literatur

• 1 Leslie RD, Evans-Molina C, Freund-Brown J. et al. Adult-Onset Type 1 Diabetes: Current Understanding and Challenges. Diabetes Care 2021; 44 (11) 2449-2456
• 2 Gregory GA, Robinson TIG, Linklater SE. et al. Global Incidence, Prevalence, and Mortality of Type 1 Diabetes in 2021 with Projection to 2040: A Modelling Study. Lancet Diabetes Endocrinol 2022; 10 (10) 741-760
• 3 Campbell-Thompson M, Fu A, Kaddis JS. et al. Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes. Diabetes 2016; 65 (03) 719-731
• 4 Vanderniet JA, Jenkins AJ, Donaghue KC. Epidemiology of Type 1 Diabetes. Curr. Cardiol. Rep 2022; 24 (10) 1455-1465
• 5 Ziegler AG, Rewers M, Simell O. et al. Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children. JAMA 2013; 309 (23) 2473-2479
• 6 Insel RA, Dunne JL, Atkinson MA. et al. Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care 2015; 38 (10) 1964-1974
• 7 Pugliese A. Insulitis in the Pathogenesis of Type 1 Diabetes. Pediatr Diabetes 2016; 17 (Suppl. 22) 31-36
• 8 Krogvold L, Wiberg A, Edwin B. et al. Insulitis and Characterisation of Infiltrating T Cells in Surgical Pancreatic Tail Resections from Patients at Onset of Type 1 Diabetes. Diabetologia 2016; 59 (03) 492-501
• 9 Rodriguez-Calvo T, Ekwall O, Amirian N. et al. Increased Immune Cell Infiltration of the Exocrine Pancreas: A Possible Contribution to the Pathogenesis of Type 1 Diabetes. Diabetes 2014; 63 (11) 3880-3890
• 10 Apaolaza PS, Balcacean D, Zapardiel-Gonzalo J. et al. The Extent and Magnitude of Islet T Cell Infiltration as Powerful Tools to Define the Progression to Type 1 Diabetes. Diabetologia 2023; 66: 1129-1141
• 11 Scherm MG, Wyatt RC, Serr I. et al. Beta Cell and Immune Cell Interactions in Autoimmune Type 1 Diabetes: How They Meet and Talk to Each Other. Mol Metab 2022; 64: 101565
• 12 Sims EK, Bundy BN, Stier K. et al. Type 1 Diabetes TrialNet Study Group. Teplizumab Improves and Stabilizes Beta Cell Function in Antibody-Positive High-Risk Individuals. Sci Transl Med 2021; 13 (583) eabc8980
• 13 Rodriguez-Calvo T, Chen YC, Verchere CB. et al. Altered β-Cell Prohormone Processing and Secretion in Type 1 Diabetes. Diabetes 2021; 70 (05) 1038-1050
• 14 Hartling SG, Knip M, Røder ME. et al. Longitudinal Study of Fasting Proinsulin in 148 Siblings of Patients with Insulin-Dependent Diabetes Mellitus. Study Group on Childhood Diabetes in Finland. Eur J Endocrinol 1997; 137 (05) 490-494
• 15 Sims EK, Evans-Molina C, Tersey SA. et al. Biomarkers of Islet Beta Cell Stress and Death in Type 1 Diabetes. Diabetologia 2018; 61 (11) 2259-2265
• 16 Tersey SA, Nishiki Y, Templin AT. et al. Islet β-Cell Endoplasmic Reticulum Stress Precedes the Onset of Type 1 Diabetes in the Nonobese Diabetic Mouse Model. Diabetes 2012; 61 (04) 818-827
• 17 Kahn SE, Halban PA. Release of Incompletely Processed Proinsulin Is the Cause of the Disproportionate Proinsulinemia of NIDDM. Diabetes 1997; 46 (11) 1725-1732
• 18 Rodriguez-Calvo T, Zapardiel-Gonzalo J, Amirian N. et al. Increase in Pancreatic Proinsulin and Preservation of β-Cell Mass in Autoantibody-Positive Donors Prior to Type 1 Diabetes Onset. Diabetes 2017; 66 (05) 1334-1345
• 19 Sims EK, Chaudhry Z, Watkins R. et al. Elevations in the Fasting Serum Proinsulin-to-C-Peptide Ratio Precede the Onset of Type 1 Diabetes. Diabetes Care 2016; 39 (09) 1519-1526
• 20 Truyen I, De Pauw P, Jørgensen PN. et al. Proinsulin Levels and the Proinsulin:C-Peptide Ratio Complement Autoantibody Measurement for Predicting Type 1 Diabetes. Diabetologia 2005; 48 (11) 2322-2329
• 21 Van Dalem A, Demeester S, Balti EV. et al. Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio. PloS One 2016; 11 (12) e0166702
• 22 Truyen I, De Grijse J, Weets I. et al. Identification of Prediabetes in First-Degree Relatives at Intermediate Risk of Type I Diabetes. Clin Exp Immunol 2007; 149 (02) 243-250
• 23 Røder ME, Knip M, Hartling SG. et al. Disproportionately Elevated Proinsulin Levels Precede the Onset of Insulin-Dependent Diabetes Mellitus in Siblings with Low First Phase Insulin Responses. The Childhood Diabetes in Finland Study Group. J Clin Endocrinol Metab 1994; 79 (06) 1570-1575
• 24 Triolo TM, Pyle L, Seligova S. et al. Proinsulin:C-Peptide Ratio Trajectories over Time in Relatives at Increased Risk of Progression to Type 1 Diabetes. J Transl Autoimmun 2021; 4: 100089
• 25 Watkins RA, Evans-Molina C, Terrell JK. et al. Proinsulin and Heat Shock Protein 90 as Biomarkers of Beta-Cell Stress in the Early Period after Onset of Type 1 Diabetes. Transl Res J Lab Clin Med 2016; 168: 96-106.e1
• 26 Snorgaard O, Hartling SG, Binder C. Proinsulin and C-Peptide at Onset and during 12 Months Cyclosporin Treatment of Type 1 (Insulin-Dependent) Diabetes Mellitus. Diabetologia 1990; 33 (01) 36-42
• 27 Wasserfall C, Nick HS, Campbell-Thompson M. et al. Persistence of Pancreatic Insulin mRNA Expression and Proinsulin Protein in Type 1 Diabetes Pancreata. Cell Metab 2017; 26 (03) 568-575.e3
• 28 Sims EK, Syed F, Nyalwidhe J. et al. Abnormalities in Proinsulin Processing in Islets from Individuals with Longstanding T1D. Transl. Res J Lab Clin Med 2019; 213: 90-99
• 29 Apaolaza PS, Chen YC, Grewal K. et al. Quantitative Analysis of Islet Prohormone Convertase 1/3 Expression in Human Pancreas Donors with Diabetes. Diabetologia 2024; 67 (12) 2771-2785